Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
04/2014
04/15/2014US8697089 H3 equine influenza A virus
04/15/2014US8697088 VLPs derived from cells that do not express a viral matrix or core protein
04/15/2014US8697087 Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
04/15/2014US8697085 Group A Streptococcus multivalent vaccine
04/15/2014US8697084 HIV consensus envelope sequences and methods for using the same
04/15/2014US8697083 Hypoallergenic chimeric proteins belonging to the lipid transfer family of parietaria judaica for use in the treatment of allergies
04/15/2014US8697082 Prevention and treatment of synucleinopathic and amyloidogenic disease
04/15/2014US8697081 Method of modulating neovascularization
04/15/2014US8697080 Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments
04/15/2014US8697079 IgE antibodies for the treatment of cancer
04/15/2014US8697078 Antibodies that inhibit metalloproteins
04/15/2014US8697077 Methods and compositions for treating autoimmune diseases
04/15/2014US8697076 Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathies
04/15/2014US8697075 Cancer specific antibody and cell surface proteins
04/15/2014US8697074 Methods and compositions for enhanced delivery of macromolecules
04/15/2014US8697073 Anti-podoplanin antibody, and pharmaceutical composition containing anti-podoplanin antibody
04/15/2014US8697072 Targeting ABCB5 for cancer therapy
04/15/2014US8697071 Identification and engineering of antibodies with variant Fc regions and methods of using same
04/15/2014US8697069 Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cells
04/15/2014US8697068 Method for treating synovial sarcoma
04/15/2014US8697067 Methods for increasing the effectiveness of antibodies and/or FCY receptor-binding active ingredients
04/15/2014US8697065 Non-natural ribonuclease conjugates as cytotoxic agents
04/15/2014US8697061 Tumor specific oligosaccharide epitopes and use thereof
04/15/2014US8697049 Modified bacteriophage including an alpha/beta small acid-soluble spore protein (SASP) gene
04/15/2014US8697047 Stable immunogenic product comprising antigenic heterocomplexes
04/15/2014CA2637903C Viable non-toxic gram negative bacteria
04/15/2014CA2566355C Influenza virus vaccine composition and methods of use
04/15/2014CA2565215C Method and system to remove soluble tnfr1, tnfr2, and il2 in patients
04/15/2014CA2495498C Use of cgrp antagonist compounds for treatment of psoriasis
04/15/2014CA2490186C Method for the treatment of multiple sclerosis
04/15/2014CA2436208C A novel virus (cryptovirus) within the rubulavirus genus and uses therefor
04/15/2014CA2427643C Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
04/15/2014CA2399298C Use of il-18 inhibitors
04/15/2014CA2383877C Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein
04/15/2014CA2328414C Methods for detecting and inhibiting angiogenesis
04/11/2014DE202014002699U1 Pharmazeutische Zusammensetzung zur Behandlung des Burnout-Syndroms A pharmaceutical composition for the treatment of the burnout syndrome
04/10/2014WO2014055998A1 Human anti-vegfr-2/kdr antibodies
04/10/2014WO2014055986A1 Methods and compositions for expanding hematopoietic stem and progenitor cells
04/10/2014WO2014055949A1 Platelet compositions and uses thereof
04/10/2014WO2014055913A1 Treatment of cancer
04/10/2014WO2014055897A2 Human monoclonal anti-pd-l1 antibodies and methods of use
04/10/2014WO2014055869A1 Treatment of cancer with alk1 antagonists
04/10/2014WO2014055867A1 Methods for accelerating immune regeneration
04/10/2014WO2014055842A1 Process for preparing stable antibody maytansinoid conjugates
04/10/2014WO2014055835A1 Alternative pathway specific antibodies for treating hemolytic diseases
04/10/2014WO2014055825A1 A formulation of mycobacterial components as an adjuvant for inducing th17 responses
04/10/2014WO2014055784A1 Methods of quantitating heavy and light chain polypeptide pairs
04/10/2014WO2014055668A1 Compositions and methods for immunotherapy
04/10/2014WO2014055663A1 Specific delivery of toxins conjugated wtih antibodies to activated matriptase
04/10/2014WO2014055648A1 Combination of anti-kir antibodies and anti-pd-1 antibodies to treat cancer
04/10/2014WO2014055544A1 Treating vascular disease and complications thereof
04/10/2014WO2014055541A1 Treatment of psychiatric conditions
04/10/2014WO2014055442A2 Compositions and methods for targeting stromal cells for the treatment of cancer
04/10/2014WO2014055415A1 Cancer treatments
04/10/2014WO2014055392A2 Method of protecting cardiac function
04/10/2014WO2014055289A1 Immunization with rabies virus vector expressing foreign protein antigen
04/10/2014WO2014054046A1 Ordered reversible fibrils, aggregates and multimers of proteins and uses thereof
04/10/2014WO2014053871A1 A method for screening a compound capable of inhibiting the notch1 transcriptional activity
04/10/2014WO2014053861A2 Staphylococcus aureus antigens
04/10/2014WO2014053612A1 Immunogenic composition
04/10/2014WO2014053607A1 Immunogenic compositions
04/10/2014WO2014053571A1 Virus-containing formulation and use thereof
04/10/2014WO2014053489A1 Compounds for treating the remyelination blockade in diseases associated with the expression of herv-w envelope protein
04/10/2014WO2014053246A1 Vaccination against japanese encephalitis, measles, mumps and rubella
04/10/2014WO2014028939A3 Targeting phosphofructokinase and its glycosylation form for cancer
04/10/2014WO2014016383A3 Glycoproteins for pseudotyping lentivectors
04/10/2014WO2014009438A3 Mycobacterial antigen vaccine
04/10/2014WO2013184912A3 Binding agents that modulate the hippo pathway and uses thereof
04/10/2014WO2013160335A3 Antigens and antigen combinations
04/10/2014WO2013132041A3 Adjuvanted formulations of booster vaccines
04/10/2014WO2013055326A3 Vaccines for human papilloma virus and methods for using the same
04/10/2014WO2013054331A8 Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
04/10/2014WO2013052607A9 Human notch1 decoys
04/10/2014WO2012099851A3 Prenatal enzyme replacement therapy
04/10/2014WO2012088210A3 Methods and compositions for wound treatment
04/10/2014WO2012082803A3 Method for inducing an immune response against avian, swine, spanish, h1n1, h5n9 influenza viruses and formulations thereof
04/10/2014WO2012061536A3 Methods for treating hair loss disorders
04/10/2014US20140099375 Methods of therapeutic treatment of eyes
04/10/2014US20140099358 Vaccines with enhanced immune response and methods for their preparation
04/10/2014US20140099340 Compositions and Methods for Targeting Stromal Cells for the Treatment of Cancer
04/10/2014US20140099339 Vaccine against streptococcus pneumoniae
04/10/2014US20140099337 Pneumococcal Vaccine and Uses Thereof
04/10/2014US20140099335 Dna vaccine
04/10/2014US20140099331 Zwitterionic immunomodulators for the teatment of asthma and allergy
04/10/2014US20140099330 Method and System for Treating Biological Tissue
04/10/2014US20140099328 Antibody product comprising n specific antibodies
04/10/2014US20140099327 Pharmaceutical composition comprising antibodies against catalase and superoxide dismutase for tumor therapy
04/10/2014US20140099325 Human monoclonal antibodies to ctla-4
04/10/2014US20140099323 Methods for treatment of inflammatory diseases
04/10/2014US20140099322 Anti-il-17f antibodies and methods of use thereof
04/10/2014US20140099320 Human binding molecules having killing activity against enterococci
04/10/2014US20140099314 S. aureus polypeptide and antibodies
04/10/2014US20140099313 Interleukin-13 binding proteins
04/10/2014US20140099312 Methods for Treating Hypercholesterolemia and Reducing LDL-C Using Antibodies to PCSK9
04/10/2014US20140099309 Use of a Trans-Signaling Approach in Chimeric Antigen Receptors
04/10/2014US20140099308 Novel EGFR-Binding Molecules and Immunoconjugates Thereof
04/10/2014US20140099307 New Dendritic Cell Co-Stimulatory Molecules
04/10/2014US20140099305 Compositions and methods for cancer immunotherapy
04/10/2014US20140099301 Antibody formulation
04/10/2014US20140099260 Anti-CD79B Antibodies and Immunoconjugates and Methods of Use
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 1823